| NCT Number | Conditions | Interventions | Sponsor/Collaborators | Phases | Start Date | Last Updated |
| NCT02100826 | Healthy Volunteers | Drug: Cephalexin | Eli Lilly and Company|Investigacion Farmacologica y Biofarmaceutica, S.A. de C.V. | Phase 1 | 2014-04-01 | 2015-05-08 |
| NCT02123446 | Healthy Volunteers | Drug: Cephalexin | Eli Lilly and Company|Investigacion Farmacologica y Biofarmaceutica, S.A. de C.V. | Phase 1 | 2014-04-01 | 2015-06-19 |
| NCT02123459 | Healthy Volunteers | Drug: Cephalexin | Eli Lilly and Company|Investigacion Farmacologica y Biofarmaceutica, S.A. de C.V. | Phase 1 | 2014-05-01 | 2015-05-08 |
| NCT02123472 | Healthy Volunteers | Drug: Cephalexin | Eli Lilly and Company|Investigacion Farmacologica y Biofarmaceutica, S.A. de C.V. | Phase 1 | 2014-05-01 | 2015-06-19 |
| NCT02490670 | Healthy | Drug: Cephalexin | Eli Lilly and Company|Investigacion Farmacologica y Biofarmaceutica, S.A. de C.V. | Phase 1 | 2015-07-01 | 2016-09-05 |
| NCT01029782 | Cellulitis | Drug: IV cefazolin plus oral probenecid and placebo cephalexin|Drug: Oral cephalexin and saline IV plus probenecid placebo | Kelowna General Hospital|Canadian Society of Hospital Pharmacists|Capital Health, Canada|Interior Health Authority, Canada | Phase 2 | 2010-05-01 | 2015-01-13 |
| NCT01767584 | Infections, Respiratory Tract | Drug: Cephalexin 1g tablets|Drug: Cephalexin 1g tablets | GlaxoSmithKline | Phase 1 | 2009-04-01 | 2013-01-10 |
| NCT01767532 | Infections, Respiratory Tract | Drug: Cephalexin 125 mg/5ml|Drug: Cephalexin 125 mg/5ml | GlaxoSmithKline | Phase 1 | 2011-01-01 | 2013-01-10 |
| NCT00352612 | Staphylococcal Infection|Abscess|Staphylococcal Skin Infection|Folliculitis | Drug: clindamycin|Drug: cephalexin | Aaron Chen|Thrasher Research Fund|Johns Hopkins University | Phase 4 | 2006-09-01 | 2013-04-01 |
| NCT01767571 | Infections, Respiratory Tract | Drug: Cephalexin 125 mg/5ml|Drug: Cephalexin 250mg/5ml | GlaxoSmithKline | Phase 1 | 2011-01-01 | 2013-01-10 |
| NCT00234949 | Mild to Moderate Uncomplicated Skin and Skin Structure Infections | Drug: cefdinir|Drug: cephalexin | Abbott | Phase 4 | 2005-03-01 | 2007-10-23 |
| NCT00003824 | Bladder Cancer | Drug: cephalexin|Procedure: surgical procedure|Drug: Ciprofloxacin | Southwest Oncology Group|National Cancer Institute (NCI) | Phase 3 | 1999-04-01 | 2012-03-07 |
| NCT01194115 | Surgical Site Infection in Obese Women Undergoing C-section | Drug: cephalexin & metronidazole|Drug: placebo | University of Cincinnati | | 2010-09-01 | 2011-11-10 |
| NCT00300092 | Finger Injuries | Drug: Cepahlexin (drug) | Children's Hospital Los Angeles | Phase 2 | 2000-09-01 | 2015-04-16 |
| NCT02911662 | Bacteriuria (Asymptomatic) in Pregnancy | Drug: Cephalexin|Drug: Nitrofurantoin | Saint Joseph Mercy Health System | | 2016-09-01 | 2016-09-20 |
| NCT01823523 | Dentofacial Deformity | Drug: Cefazolin, Cephalexin, Clindamycin | Atlantic Center for Oral and Maxillofacial Surgery | | 2013-06-01 | 2015-01-12 |
| NCT00676130 | Cellulitis | Drug: trimethoprim-sulfamethoxazole|Drug: Cephalexin | Brigham and Women's Hospital | | 2007-05-01 | 2012-08-12 |
| NCT00957827 | Through-and-through Lip Lacerations | Drug: keflex|Drug: placebo | University of Pennsylvania | | 2009-08-01 | 2015-12-09 |
| NCT01912651 | Facial Defect | Drug: cephalexin | University of Michigan | Phase 4 | 2013-07-01 | 2016-05-23 |
